Bile duct ligation increased dopamine levels in the cerebral cortex of rats partly due to induction of tyrosine hydroxylase
British Journal of Pharmacology · 2023
DOI: 10.1111/bph.16041 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2023. Verfasst von Weimin Kong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Neuroblastoma, Liver Failure. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Project 211.
Abstract (Originalsprache)
Background and Purpose Liver failure is associated with psychiatric alterations, partly resulting from the increased brain dopamine levels. We investigated the relationship between increased dopamine levels and mental abnormalities using bile duct ligation (BDL) rats and the mechanism by which liver failure increased dopamine levels in SH‐SY5Y cells. Behavioural tests were carried out on day 13 and 27 following BDL, along with measurements of dopamine and metabolites, expressions of enzymes and transporters related to dopamine metabolism, and its transport into the cortex and the hippocampus. SH‐SY5Y cells were used to investigate whether NH 4 Cl, bile acids and bilirubin affected expression of tyrosine hydroxylase or not. Tyrosine hydroxylase (TH) expression in SH‐SY5Y cells co‐incubated with bilirubin and signal pathway inhibitors was measured. Key Results Open‐field test results demonstrated BDL rats showed anxiety‐like behaviour, accompanied by increased dopamine levels and expression of TH protein in the cortex. Membrane bound long form (MB)‐COMT, slightly but significantly decreased. SH‐SY5Y cells indicated that increased bilirubin levels was a factor in inducing TH expression. Both inhibitor of NF‐κB pathway BAY 11‐7082 and silencing NF‐κB p65 reversed bilirubin‐induced upregulation of TH protein. NF‐κB activator TNF‐α increased expression of TH protein. Roles of bilirubin in increases of TH protein expressions and dopamine levels were measured using hyperbilirubinemia rats. Anxiety‐like behaviour, was associated with increased dopamine levels and TH protein expressions in hyperbilirubinemia rats. Conclusion and Implications BDL significantly increased dopamine levels in rat cortex partly due to bilirubin‐mediated TH induction. Increased bilirubin induced TH expression via activating NF‐κB signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
- School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu, Anhui, China.
- Hunan Provincial People's Hospital (The first-affiliated hospital of Hunan Normal University), Changsha, China.
ORCID-Profile: Xueying Sun, Peihua Liu, Li Liu
Förderung
- National Natural Science Foundation of China
- Project 211
Zitieren
APA
Kong, W., Sun, X., Yu, S., Liu, P., Zheng, X., Zhang, J., Zhu, L., Jiang, T., Jin, M., Gao, J., Fan, X., Liu, X., & Liu, L. (2023). Bile duct ligation increased dopamine levels in the cerebral cortex of rats partly due to induction of tyrosine hydroxylase. British Journal of Pharmacology. https://doi.org/10.1111/bph.16041
Vancouver
Kong W, Sun X, Yu S, Liu P, Zheng X, Zhang J, et al. Bile duct ligation increased dopamine levels in the cerebral cortex of rats partly due to induction of tyrosine hydroxylase. British Journal of Pharmacology. 2023. doi:10.1111/bph.16041
BibTeX
@article{Kong2023,
author = {Kong, Weimin and Sun, Xueying and Yu, Siyu and Liu, Peihua and Zheng, Xiaoke and Zhang, Jiaxin and Zhu, Liang and Jiang, Tianxin and Jin, Mengmeng and Gao, Jinghui and Fan, Xiaomin and Liu, Xiaodong and Liu, Li},
title = {Bile duct ligation increased dopamine levels in the cerebral cortex of rats partly due to induction of tyrosine hydroxylase},
journal = {British Journal of Pharmacology},
year = {2023},
doi = {10.1111/bph.16041}
}
EUVIMED